TABLE 1

Kp brain of 11 P-gp substrates in wild-type and mdr1a/1b(−/−) mice, and the observed Kp brain ratios

Quinidine, loperamide, digoxin, dexamethasone, and vinblastine were infused via jugular vein for 100 min at a dose rate of 838, 264, 197, 135, and 346 nmol · h−1 · kg−1 after rapid intravenous infusion for 1 min at a dose rate of 692, 201, 473, 1216, and 1248 nmol · min−1 · kg−1, respectively (n = 4–5). The brain-to-plasma concentration ratios (Kp brain) were measured at 100 min. The Kp brain ratios were obtained by dividing the Kp brain in mdr1a/1b(−/−) mice by that in wild-type mice. Each value represents the mean ± S.E.M., with the exception of loratadine. The S.E.M. was calculated according to the law of propagation of error.

SubstrateKp brainObserved
Wild TypeMdr1a/1b(−/−)Kp brain Ratio
ml/g of brain
Quinidine0.230 ± 0.0089.06 ± 1.0539.4 ± 3.4
Loperamide0.0790 ± 0.00682.48 ± 0.2531.4 ± 2.9
Digoxin0.0402 ± 0.00200.806 ± 0.04620.1 ± 1.1
Risperidonea0.780 ± 0.0298.02 ± 0.2910.3 ± 0.4
Indinavirb0.0842 ± 0.02500.810 ± 0.1769.61 ± 2.50
Dexamethasone0.135 ± 0.0051.20 ± 0.038.83 ± 0.26
Vinblastine0.379 ± 0.0183.03 ± 0.127.97 ± 0.34
Paclitaxelc0.500 ± 0.0883.96 ± 0.217.91 ± 1.03
Verapamild0.429 ± 0.0593.30 ± 0.917.71 ± 1.68
Loratadinee1.603.302.06
Diazepama1.96 ± 0.192.31 ± 0.191.18 ± 0.11
  • a Data were taken from Doran et al. (2005).

  • b Data were taken from Kim et al. (1998).

  • c Data were taken from Kemper et al. (2004).

  • d Data were taken from Hendrikse et al. (1998).

  • e Data were taken from Chen et al. (2003).